SAB Biotherapeutics, Inc. earnings per share and revenue

SABS earnings per share for the last quarter are -1.12 USD whereas the estimation was -1.11 USD which accounts for -1.27% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 120.00 k USD. Estimated earnings per share for the next quarter are -1.16 USD, and revenue is expected to reach 120.00 k USD. Also watch annual changes over time to get a bigger picture of SABS earnings per share and revenue dynamics.